Wells Fargo Maintains Overweight on Gilead Sciences, Raises Price Target to $190
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
Wells Fargo analyst Mohit Bansal maintains Gilead Sciences (NASDAQ:GILD) with a Overweight and raises the price target from $165 to $190.
Wells Fargo analyst Mohit Bansal maintains Gilead Sciences (NASDAQ:GILD) with a Overweight and raises the price target from $165 to $190.